Julie L. Gerberding Merck & Co., Inc. (MRK) insider trading activity

Julie L. Gerberding is EVP, Chief Patient Officer of Merck & Co., Inc.. Currently has a direct ownership of 48,712 shares of MRK, which is worth approximately $4.54 Million. The most recent transaction as insider was on May 02, 2015, when has been sold 3,818 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.7K

0% 3M change

0% 12M change

Total Value Held $4.54 Million

Julie L. Gerberding Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 02 2015	BUY Exercise of conversion of derivative security	-	3,818 Added 13.09%	25,359 Common Stock
Feb 23 2015	BUY Grant, award, or other acquisition	$159,509 $58.3 p/Share	2,736 Added 11.35%	21,374 Common Stock

Also insider at

MCK

MCKESSON CORP Healthcare

Director

HLVX

HilleVax, Inc. Healthcare

Director

JLG